AlphaStocks
4.9
Weak

Edwards Lifesciences Corp (EW)

Health Care / Health Care Equipment

S&P 500

$83.18

Below average on several measures. Research carefully.

Weak

Score based on 5 of 5 models — high confidence

#591out of 1126 in Health Care

Is Edwards Lifesciences Corp a Good Investment in 2026?

Edwards Lifesciences Corp (EW) scores 4.9 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates Edwards Lifesciences Corp as Attractive (6/9). The Lynch model is the least favorable, rating it Neutral. Edwards Lifesciences Corp currently trades above its estimated fair value of $61, suggesting limited upside at current prices. Edwards Lifesciences Corp ranks #591 out of 1126 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E45.4ROE8.8Market Cap48B

Estimated Fair Value

$61.0636% above

Trading above estimated fair value. P/e of 45x implies high growth expectations. eps growth of -74% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

Significantly above fair value

Lynch

Neutral

PEG 3.7 · Stalwart

Greenblatt

Attractive

Top 25% (rank 19%)

Frequently Asked Questions

Is Edwards Lifesciences Corp (EW) a good investment?
Based on AlphaStocks' composite analysis, Edwards Lifesciences Corp (EW) scores 4.9 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trading above estimated fair value. P/e of 45x implies high growth expectations. eps growth of -74% may not justify the premium.
What is Edwards Lifesciences Corp's Piotroski F-Score?
Edwards Lifesciences Corp's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is EW overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $61, EW appears overvalued. The stock currently trades 36% above its estimated fair value. Trading above estimated fair value. P/e of 45x implies high growth expectations. eps growth of -74% may not justify the premium.
How does EW compare to other Health Care stocks?
Edwards Lifesciences Corp ranks #591 out of 1126 stocks in the Health Care sector, placing it in the top 52% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about EW?
AlphaStocks evaluates EW using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 4.9/10.

Similar Stocks

PARRAZNFTI

Compare EW with

EW vs PARREW vs AZNEW vs FTI

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer